Clinical Trial Update: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial evaluating the safety, pharmacokinetics, and pharmacodynamics of iron isomaltoside (Monofer) in individuals with anemia or iron …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hematologic Diseases
• Iron Deficiency Anemia
• Iron Metabolism Disorders

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Anemia, Deficiency Diseases | Phase 1 | Status: COMPLETED